Lydia A Boateng, MD | |
1517 Pond Rd, Allentown, PA 18104-2253 | |
(610) 395-4444 | |
(610) 366-7886 |
Full Name | Lydia A Boateng |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 1517 Pond Rd, Allentown, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275714024 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 447159 (Pennsylvania) | Primary |
2080P0207X | Pediatrics - Pediatric Hematology-oncology | MD447159 (Pennsylvania) | Secondary |
Entity Name | Lehigh Valley Physician Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients, at the 2015 annual meeting of the American Society for Clinical Oncology. This application expands the investigational utility of Epic Sciences' no cell left behind™ platform to characterize circulating tumor cell (CTC) genomic alterations.
Kidney transplant recipients are known to have a higher risk of cancer, compared to the general population, due to the need to take immunosuppressive drugs to prevent organ rejection. Results published today from a significant, long-term study suggest that no single medication appears to increase this cancer risk.
Mandatory alcohol testing programs for truck and bus drivers have contributed to a significant reduction in alcohol involvement in fatal crashes, according to a new study by researchers at the Mailman School of Public Health and the Johns Hopkins Bloomberg School of Public Health. Based on a study sample of nearly 70,000 motor carrier (heavy trucks and buses) drivers and over 83,000 non-motor-carrier (car) drivers, the estimated net effect attributed to the mandatory alcohol testing programs for drivers of heavy trucks and buses was a 23% reduced risk of alcohol involvement in fatal crashes.
Most women diagnosed with ovarian cancer undergo surgery to remove as many of the tumors as possible. However, it is usually impossible to eliminate all of the cancer cells because they have spread throughout the abdomen. Surgery is therefore followed by 18 weeks of chemotherapy.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Lydia A Boateng, MD 1517 Pond Rd, Allentown, PA 18104-2253 Ph: (610) 395-4444 | Lydia A Boateng, MD 1517 Pond Rd, Allentown, PA 18104-2253 Ph: (610) 395-4444 |
News Archive
Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients, at the 2015 annual meeting of the American Society for Clinical Oncology. This application expands the investigational utility of Epic Sciences' no cell left behind™ platform to characterize circulating tumor cell (CTC) genomic alterations.
Kidney transplant recipients are known to have a higher risk of cancer, compared to the general population, due to the need to take immunosuppressive drugs to prevent organ rejection. Results published today from a significant, long-term study suggest that no single medication appears to increase this cancer risk.
Mandatory alcohol testing programs for truck and bus drivers have contributed to a significant reduction in alcohol involvement in fatal crashes, according to a new study by researchers at the Mailman School of Public Health and the Johns Hopkins Bloomberg School of Public Health. Based on a study sample of nearly 70,000 motor carrier (heavy trucks and buses) drivers and over 83,000 non-motor-carrier (car) drivers, the estimated net effect attributed to the mandatory alcohol testing programs for drivers of heavy trucks and buses was a 23% reduced risk of alcohol involvement in fatal crashes.
Most women diagnosed with ovarian cancer undergo surgery to remove as many of the tumors as possible. However, it is usually impossible to eliminate all of the cancer cells because they have spread throughout the abdomen. Surgery is therefore followed by 18 weeks of chemotherapy.
› Verified 4 days ago
Dr. Ruchi Gupta, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 401 N 17th St, Suite 309, Allentown, PA 18104 Phone: 610-437-6687 | |
Dr. Douglas Mchale, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-7712 Fax: 224-484-1306 | |
Dr. Sajani Jitendra Sukhadia, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1611 Pond Rd Ste 400, Allentown, PA 18104 Phone: 610-402-8000 | |
Dr. Heather Noreen Becker, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-9750 | |
Sara S Viessman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1627 W Chew St, Suite 601, Allentown, PA 18102 Phone: 610-969-2555 | |
Paige Payne, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 450 Chew St Ste 203, Allentown, PA 18102 Phone: 484-503-3058 | |
Daniel Helmut Ublagger, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd Fl 6, Allentown, PA 18103 Phone: 610-402-7712 Fax: 484-224-1306 |